COVID-19

Today we’re celebrating 3 pharmacists for their amazing work organizing a drive-through testing center.

The letter was issued by the American Pharmacists Association, the Alliance for Pharmacy Compounding, the National Community Pharmacists Association, and the National Alliance of State Pharmacy Associations.

During the COVID-19 pandemic, pharmacists are concerned not only about shortages in drugs that could treat the virus, but also medications for managing other conditions.

The waivers were approved within days of the states' submissions.

Curtis E. Haas, PharmD, FCCP, editor-in-chief of Pharmacy Times: Directions in Health-System Pharmacy, and chief pharmacy officer for the University of Rochester’s health care system, discusses preparation for potential patient surge due to COVID-19.

Today’s pharmacy hero is Diane Berkley, CPhT. In addition to working full time at a local hospital during the day, Berkley also works part-time at a community pharmacy.

The FDA has issued a statement regarding action to help increase the supply of ventilators, ventilator tubing connectors, and ventilator accessories during the COVID-19 pandemic.

More than 60 front-end, nonprescription products are currently available for purchase at drive-thru windows.

The researchers noted that it is still important for people to cover their eyes, hands, and mouth to avoid virus particles spread from another person.

More than 1800 members registered for the town hall-style meeting, during which Rep. Buddy Carter (R-GA), a pharmacist and congressman, briefed attendees about emergency relief efforts currently in development by policymakers, efforts to address pharmacy direct and indirect remuneration (DIR) fees, and other key issues.

According to reporting by NPR, the decision may be in response to backlash from the health care community

For specialty pharmacies, contingency plans for COVID-19 are not as simple as moving a workforce to their remote access solutions.

Today we're thanking a pharmacist who has spent over 30 years caring for his community in New Jersey.

CVS Health said it has implemented new protocols to continue to combat the pandemic and to protect the health of their employees.

These professional organizations are aware that some medications are being prophylactically prescribed as potential treatments for COVID-19.

Ben Harding, a P4 student, discusses the scenario of being a pharmacy student during the COVID-19 pandemic.

The EUA designation allows the test to be used to detect SARS-CoV-2, the virus that causes COVID-19, for the duration of the continuing pandemic.

While remdesivir is not FDA-approved to treat the novel coronavirus, the orphan drug status would provide 7 years of exclusive marketing in the United States and tax credits on research and development costs once the drug was approved.

Today, we’re celebrating Jennifer Cardona, PharmD, who works at an independent pharmacy in Puerto Rico.

The FDA released a statement on taking action to increase US supplies to support the response to the coronavirus disease 2019 by providing instructions to manufacturers importing personal protective equipment and other devices.

The new edge-computing platform may expand the arsenal of health surveillance tools used to forecast seasonal flu and other viral respiratory outbreaks, such as COVID-19 or severe acute respiratory syndrome.

Here is an overview of reported investigations of existing medications.

The program will award grants for training and development of educational resources for employees in high risk occupations who serve the public during emergencies and who need skills to protect their own health.

Gunda Siska, RPh, PharmD, discusses what she is doing as a hospital pharmacist to stay healthy.

Pennsylvania Governor Tom Wolf’s administration has decided that in-state and out-of-state health care providers can treat patients via telemedicine during the coronavirus disease 2019 pandemic.